1. Introduction {#s0005}
===============

Herbal medicines (HMs), also called botanical medicine or phytomedicine, refers to using a plant\'s seeds, berries, roots, leaves, bark or flowers with minimal or no industrial processing that have been used for medicinal purposes. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease [@bib1]. According to the World Health Organization, about 80% of world\'s population relies on HMs for some aspect of their primary healthcare, and the worldwide annual market for HM products approaches US\$ 60 billion [@bib2].

With the expansion of HMs\' market, the issue on how to apply up-to-date scientific technologies on HMs to assure their quality, safety and efficacy has been arousing great attention in a broad range of fields [@bib3]. Most herbal medicines and their derivative products were often prepared from crude plant extracts, which comprise a complex mixture of different phytochemical constituents (plant secondary metabolites). The chemical features of these constituents differ considerably among different species [@bib4]. Therefore, the qualitative analysis of HMs was described as "complex system research", which is really a challenging task for scientists.

In recent decade, liquid chromatography coupled with mass spectrometry (LC--MS) has become the most selective technique for rapid screening and characterization of known and unknown constituents from the extracts of HMs. Interfaces including atmospheric pressure chemical ionization (APCI) and electrospray ionization (ESI) have been successfully used in LC--MS configuration, which are well-suited for HM analysis. There are three common single mass analyzers: quadrupole (Q), ion trap (IT) and time-of-flight (TOF). With purposeful combination, triple quadrupole (TQ), Q-IT, IT-TOF, Q-TOF and TOF--TOF, as well as 3D traps including Fourier transform ion cyclotron resonance (FTICR) and Orbitrap, were commercially available and have already been wildly used for HM analysis.

It must be pointed out that TOF-MS is a powerful tool, which is capable of 10,000 or more resolving power expressed in terms of full peak width at one-half maximum (FWHM). TOF-MS has a high acquisition speed and provides accurate mass measurement (possibility to yield mass accuracy \<2 ppm with an adequate calibration range) as well as full scan spectral sensitivity. Accurate mass measurement gives the elemental composition of parent and fragment ions, used for the identification of unknown species and a greater differentiation of isobaric species (two different compounds with the same nominal mass but different elemental composition, also with different exact masses) [@bib3], [@bib5]. Correspondingly, ion trap analyzers are especially suitable for multiple fragmentation steps (MS^*n*^).

In linear ion traps, ions are isolated and accumulated due to a special arrangement of hyperbolic and ring shaped electrodes as well as oscillating electric fields. Then the ions can be fragmented in a similar way as described above by collision-induced decomposition (CID). This process can be repeated in a sequential manner, so that valuable structural information is obtained [@bib6], which can be used for the differentiation of isomers (two different compounds with the same exact mass and elemental composition).

In this sense, the combination of LC/TOF-MS accurate mass measurements to generate empirical formulae and LC/IT-MS^*n*^ providing additional fragmentation data for structure confirmation represents a powerful methodology for the analysis of complex systems. Currently, this strategy has been successfully developed and applied in the analysis of environmental contaminants [@bib7], [@bib8], HMs [@bib9], [@bib10], [@bib11], [@bib12], metabolites [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18] and many other fields.

This review intends to summarize the advantages of the combination of TOF-MS and IT-MS^*n*^, hyphenated to LC for qualitative analysis of complex constituents in HM products and metabolites of HM-treated biological samples. Two main aspects are involved in this review: (1) a brief introduction of general features of TOF-MS and IT-MS, including the recent advances in the application of hybrid IT-TOF/MS and (2) discussion of the integrated strategy applied to HM qualitative analysis, including the summary of relevant reports from 2006 to the present.

2. General features and advantages of the combination of LC-TOF-MS and LC-IT-MS {#s0010}
===============================================================================

2.1. TOF-MS {#s0015}
-----------

### 2.1.1. Accurate mass measurements {#s0020}

One of the main attributes of TOF instrument is its accurate mass measurement, which gives the elemental composition of parent and fragment ions and can be used for the identification of unknown compounds and the differentiation of isobaric compounds. The measurement of accurate masses within 5 ppm is widely accepted for the verification of the elemental compositions [@bib5]. To achieve such accurate mass measurement, TOF instruments require frequent tuning and calibration of the spectrometer.

In compatible with TOF-MS analyzer, an 'in-house library' (containing the chemical information of components from relative HMs) is always constructed for screening constituents from HMs. For non-target compounds recorded in the in-house library, the exact elemental compositions are generally deduced from several steps. First, low fragmentor voltages are used and the software of TOF-MS will list the possible molecular composition according to accurate mass measurements and different criteria such as double bond equivalent (DBE) index, 'show isotopic' function and so on. Second, the most probable molecular formulae (corresponding to the criteria) are selected and searched against exhaustive in-house chemical library. At last, the library hits by each chemical formula are recorded [@bib19]. This strategy can make screening non-target components from HMs an easy task on the basis of accurate mass measurements by TOF-MS.

### 2.1.2. Fragmentation {#s0025}

Fragmentor voltage is crucial for providing characteristic fragment ions in the MS spectra resulted from CID in-source, which corresponds to the MS^*n*^ fragmentation. Generally, the fragmentor voltage needs to be adjusted since various types of components in HMs produce characteristic fragment ions at different fragmentor voltages [@bib19]. Thus, with dynamic adjustment of fragmentor voltage, TOF-MS can provide valuable structural information by producing various characteristic fragment ions together with their elemental compositions [@bib3]. However, the parent ion of the fragment ions may not be easier to confirm, particularly when analyzing complex matrix samples. This situation may complicate the identification and confirmation process and affect the deduction of fragmentation pathways for the analytes of interest. Fortunately, IT-MS can solve this problem easily by its own features, which will be introduced in detail in the following section.

2.2. IT-MS {#s0030}
----------

A different concept is followed in ion trap analyzer, which is especially suitable for multiple fragmentation steps (MS^*n*^) rather than quantitative studies. In linear ion traps, ions are isolated and accumulated due to a special arrangement of hyperbolic and ring shaped electrodes as well as oscillating electric fields. Then the ions can be fragmented in a similar way as described above by CID in TOF-MS analyzer. This process can be repeated up to 12 stages as needed [@bib6]. Thus, the structures of target components could be tentatively elucidated by applying the MS^*n*^ process, which solve the problem that TOF-MS cannot lock the target parent and fragment ions. This feature has made IT-MS to be a powerful tool for the differentiation of isomers, and even the structure elucidation of unknown compounds. However, IT-MS cannot provide information with high resolution and may not ensure good precursor ion selectivity. Apparently, the combination of TOF-MS and IT-MS has complementary advantages, which can overcome their respective defects during the analysis procedures.

2.3. Procedures of the combination of LC-TOF-MS and LC-IT-MS for structure elucidation {#s0035}
--------------------------------------------------------------------------------------

According to large amounts of literatures, we come to the multiple relative procedures for the identification and confirmation of non-target compounds: (1) accurate mass data within 5 ppm, provide the authentic molecular formula with well-matching isotope profile and DBE; (2) under certain conditions, the fragment ions due to CID in-source fragmentation appear in TOF-MS spectrum assisted structure elucidation; (3) utilize IT-MS to conduct multiple stages analysis and confirm the target fragment ions, including the differentiation of isomers. Finally, reference standard (if available) can be used to validate the conclusion. By applying these procedures, the unambiguous identification of multiple components and the differentiation of isobaric species and isomers will be feasible.

2.4. LC-hybrid-IT-TOF/MS {#s0040}
------------------------

As one of the latest LC/MS instrumentation designs, hybrid ion trap/time-of-flight mass spectrometry coupled with high-performance liquid chromatography (HPLC-hybrid-IT-TOF-MS) provides higher sensitivity and accuracy than both TOF and IT-MS. In particular, multiple scans of natural products in MS^*n*^ modes and accurate mass measurements can be performed simultaneously through data-dependent acquisition [@bib20]. This tandem mass technique has raised the qualitative analysis of HMs to a new height both in analytic speed and accuracy, which integrate the advantages of both IT and TOF. Recently, it has been applied to HMs analysis and also been confirmed to be a very powerful tool on the global identifications of both target and non-target components [@bib21].

3. Application of HPLC-IT/TOF-MS for the qualitative analysis of medicinal plants {#s0045}
=================================================================================

3.1. Study of chemical constituents {#s0050}
-----------------------------------

### 3.1.1. Identification of components {#s0055}

The LC coupled with IT-MS and TOF-MS strategy has now been widely used in many fields, especially in qualitative analysis of HMs. In spite of its enormous analytical potential, not many articles have been published as yet on the analysis of HMs mainly due to the still high costs of the technique. It should be noticed that, the use of LC-hybrid-IT-TOF/MS on HM analysis has increased quickly in the last two years (see [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}), which will dominate the field of HM qualitative analysis in the near future.Table 1Combination of TOF-MS and IT-MS for qualitative analysis of HM samples.AnalytesMatrixLC/stationary phaseAnalyzersYearRef.4 N-alkylamides*Spilanthes acmella*HPLC/C~18~IT-TOF/MS^*n*^2011[@bib25]21 compounds including amino acids, phenolic acids, flavonoid glycoside, terpene glycoside and phthalide*Xuebijing injection*HPLC/C~18~DAD-TOF-MS; IT-MS^*n*^2011[@bib26]Over 39 compoundsFructus *corni*UFLC/C~18~IT-TOF/MS^*n*^2011[@bib27]18 phenolic constituents, including moscatilin and gigantol*Dendrobium*HPLC/C~18~IT-TOF/MS^*n*^2010[@bib11]Rutaecarpine and its 2 derivativesStandard compoundIT-TOF/MS^*n*^2010[@bib28]46 compounds including 3 phenolic compounds and 1 triterpenoid in licorice extract; 25 compounds in rat plasmaLicorice and rat plasmaHPLC/C~18~DAD; TOF-MS;QIT-MS^*n*^2010[@bib12]62 flavone and isoflavone glycoconjugateRoot and leaf tissues of *Lupinus reflexus*HPLC/C~18~IT-MS^*n*^; Q-TOF-MS2010[@bib29]5 lignans components*Schisandra* lignans extract and rat plasmaHPLC/C~18~IT-TOF/MS^*n*^2010[@bib21]Salvinorin A*Salvia divinorum*TLC/SiO~2~DESI-TOF-MS; IT-MS^*n*^2010[@bib30]Phenolic compoundsOlive leafHPLC/C~18~TOF-MS; IT-MS^*n*^2010[@bib31]Flavonoids, phenolic acids, ellagitanins, hexahydroxydiphenoyl and derivatives, etc.*Cistus ladanifer shrub* aqueous extractHPLC/C~18~DAD; TOF-MS; IT-MS^*n*^2010[@bib32]GallotanninsChinese galls--MALDI-QIT-TOF/MS^*n*^2009[@bib33]30 ginsenosides and 20 lignans*Shengmai injection*HPLC/C~18~IT-TOF/MS^*n*^2009[@bib24]28 cynandione A derivativesRadix *Cynanchum wilfordii* and *C. auriculatum*HPLC/C~18~IT-MS^n^; QTOF-MS2009[@bib34]23 furocoumarinsRadix *Angelica dahurica*HPLC/C~18~DAD; QIT-MS^*n*^; TOF-MS2009[@bib35]ProanthocyanidinBlueberry leavesHPLC/C~18~IT-TOF/MS^*n*^2009[@bib36]25 dibenzocyclooctadiene lignans, including seven groups of lignan isomers*Schisandra Chinensis*HPLC/C~18~UV; IT-MS^*n*^; TOF-MS2009[@bib37]Phenolic compounds including verbascoside and its derivatives, diglucuronide derivatives of apigenin and luteolin, and eukovoside. gardoside, verbasoside, cistanoside F, theveside, campneoside I, chrysoeriol-7-diglucuronide, forsythoside A and acacetin-7-diglucuronideLemon verbena extractHPLC/C~18~DAD-TOF-MS; IT-MS^*n*^2009[@bib38]Pregnane glycosides*Cynanchum auriculatum*HPLC/C~18~IT-TOF/MS^*n*^2009[@bib39]21 lignans in Schisandra chinensis; 11 lignans in rat plasma*Schisandra chinensis* and rat plasmaHPLC/C~18~DAD; TOF-MS; QIT-MS^*n*^2009[@bib40]10 constituents including resveratroloside, polydatin, emodin-8-O-glucoside, resveratrol, torachryson-8-O-glucoside, emodin-1-O-glucoside, torachryson-8-O-(6′-acetyl)glucoside, physcion-8-O-glucoside, physcion-8-O-(6′-acetyl)glucoside and emodin*Polygonum cuspidatum* Sieb. et ZuccHPLC/C~18~QIT-TOF/MS^*n*^2009[@bib41]25 anthocyaninsBlueberryHPLC/C~18~UV; IT-TOF/MS^*n*^2009[@bib42]C-20-nonoxygenated ent-kauranes and two subtypes of C-20-oxygenated ent-kauranesStandard compounds--IT-MS^n^; QTOF-MS2008[@bib43]Major components from Astragali Radix43 Radix *Astragali* samplesHPLC/C~18~IT-TOF/MS^*n*^2008[@bib44]Anthocyanins and chlorogenic acidDried calyces of *Hibiscus sabdariffa* LCEIT-MS^*n*^; TOF-MS2008[@bib45]87 compounds including non-target components*Mai-Luo-Ning injection*HPLC/C~18~IT-TOF/MS^*n*^2008[@bib46]Terpene lactonesStandard compounds--IT-MS^*n*^; QTOF-MS2008[@bib47]8 C-21 steroidal glycosides*Hoodia gordonii*HPLC/C~18~IT-MS^*n*^;TOF-MS2008[@bib48]7 tropane alkaloid including tropine, belladonnine, norhyoscyamine, apoatropine, hyoscyamine, 6beta-hydroxyhyoscyamine, and scopolamine*Atropa belladonna* LCEIT-MS^*n*^;TOF-MS2008[@bib49]40 phenolic and diterpenoid constituentsRadix *Salvia miltiorrhiza*HPLC/C~18~DAD; QIT-MS^*n*^;TOF-MS2007[@bib23]Dammarane-type triterpenoid saponins*Bacopa monnieri*--ESI-IT-MS^*n*^, AP-MALDI-IT-MS^*n*^, MALDI- IT-TOF/MS^*n*^2007[@bib50]Sesamin and gmelinolStandard compounds--IT-TOF/MS^*n*^2007[@bib51]7 flavonolignans including Silychristins A and B , silydianin , silybins A and B, and isosilybins A and B*Silybum marianum*Semi-microHPLC/C~18~IT-TOF/MS^*n*^2007[@bib52]Resveratrol glycosides including resveratrol diglucoside (M1), trans- and cis-resveratrol acetylhexosidesTransgenic *Arabidopsis*HPLC/C~18~UV; QTOF-MS; IT-MS^*n*^2007[@bib53]Podophyllotoxin and its 4′-demethyl-4beta-substituted derivativesStandard compounds--IT-TOF/MS^*n*^2007[@bib54]PuerarinStandard compounds--IT-TOF/MS^*n*^2007[@bib55]13 steroid saponinsRhizomes of *Dioscorea panthaica*--QTOF-MS; IT-MS^*n*^2006[@bib56]Differentiation of 3 pairs of aconite alkaloid isomers*Aconitum nagarum* var. *lasiandrum*--QTOF-MS;IT-MS^*n*^2006[@bib57]14 betacyanins*Amaranthus tricolor, Gomphrena globosa,* and *Hylocereus polyrhizus*--MALDI-QIT-TOF/MS^*n*^2006[@bib58]

Qualitative analysis of HMs involves the confirmation of target components and elucidation of non-target components and the identification of unknown compounds. [Table 1](#t0005){ref-type="table"} summarizes the different studies performed regarding the qualitative analysis of chemical constituents and biotransformation products in HMs or HM-treated biological matrices using the integrated strategy. The benefit of using a TOF analyzer that allows it to perform full-scan acquisitions with superior sensitivity and high mass accuracy, makes the qualitative analysis of chemical constituents in HMs easier, quicker and more accurate. This is due to the fact that monitoring a specific mass of an analyte does not need to be predefined before data acquisition and this fact allows us to detect the presence of an unlimited number of chemical constituents in a certain HM without reanalysis, which is not easily achieved by the SIM or MRM mode of quadrupole mass analyzers (Q, TQ) [@bib22]. On the other hand, besides the screening of fragment ions procedure performed by CID in-source fragmentation of TOF-MS, the IT analyzer can deal with the MS/MS and MS^*n*^ processes with higher selectivity and stability of target ions than TOF-MS. This is because the (Q)-IT analyzer consisting of a ring electrode and two endcap electrodes with hyperbolic surfaces and IT is operated in a "mass-selective stability" mode of operation. In this mode, analogous to the operation of a quadrupole mass filter, rf and dc voltages applied to the ring electrode are ramped to allow stability, hence storage, of a single (increasing) value of *m*/*z* in the IT analyzer [@bib6].

An illustrative example has been reported by our research group [@bib23], in which Radix *Salvia miltiorrhizae* (Dan-shen) was analyzed by using the integrated strategy of HPLC coupled with DAD, TOF-MS and QIT-MS. In order to elucidate the components of *S. miltiorrhizae*, the first step was to propose the fragmentation pathways of the reference compounds. We tried two approaches: one was based on the accurate masses of the parent ions and fragment ions produced by dynamic adjustment of the fragmentor voltage in TOF-MS; the other was based on MS^*n*^ analysis (*n*=2--6) of IT-MS for the confirmation of parent and fragment ions. Take salvianolic acid B as an example (see [Fig. 1](#f0005){ref-type="fig"}), from the TOF-MS spectrum ([Fig. 1](#f0005){ref-type="fig"}(a)) we can see that the accurate mass of salvianolic acid B can be obtained under low fragmentor voltage. Afterwards, a series of fragment ions were characterized under high fragmentor voltage, which were less than the fragment information acquired by Q-IT-MS^*n*^ (see [Fig. 1](#f0005){ref-type="fig"}(b)). In addition, Q-IT-MS can "trap" the target parent ion with high selectivity, so Q-IT-MS was performed as structure elucidation tool while TOF-MS as component identification tool, combined with DAD for more reliable components recognition. [Fig. 2](#f0010){ref-type="fig"} shows the DAD, TOF-MS and IT-MS spectra. By applying this strategy, 40 constituents including phenolic and diterpenoid constituents were identified within 30 min based on their positive and negative ion ESI mass spectra and liquid chromatographic information.Figure 1TOF-MS spectra (a) and IT-MS^1--5^ spectra (b) of salvianolic acid B.Figure 2HPLC--UV chromatogram monitored at 280 nm (a), TIC profile from HPLC/ESI-TOF-MS (b), and TIC profile from HPLC/ESI--MS^*n*^ (c) of phenolics and diterpenoids in Radix *Salvia miltiorrhizae*.

Another research reported by Zheng et al. [@bib24] must be highlighted, which presents a modified and universally applicable diagnostic fragment-ion-based extension strategy (DFIBES) to efficiently process the information acquired by LC-(ESI)-hybrid-IT-TOF/MS, facilitating the structural determination of serial components contained in traditional Chinese medicine prescription (TCMP). The key advantage of DFIBES is that it facilitates the rapid classification of the complicated peaks into well-known chemical families, which significantly simplifies the complicated procedures of structural characterization due to the specific advantages of hybrid-IT-TOF/MS analyzer. *Shengmai* injection, composed of *Panax ginseng*, Radix *ophiopogonis* and *Schisandra chinensis*, was taken as a TCMP example to conduct and validate the proposed DFIBES. Diagnostic fragment ions (DFIs) for each chemical family contained in *Shengmai* injection were firstly determined or proposed from the separated analysis of 15 authentic standards and the extract of S. *chinensis*. The ESI--MS^*n*^ fragmentation patterns of ginsenosides and lignans were then systematically studied for developing the 'structure extension' approach. Upon LC-IT-TOF/MS analysis and DFIBES, more than 30 ginsenosides and 20 lignans have been rapidly detected and identified from *Shengmai* injection, supporting that the DFIBES achieved by LC-hybrid-IT-TOF/MS is a powerful strategy and would be applicable for the components identification from TCMP and other complicated mixtures.

### 3.1.2. Differentiation of isomers {#s0060}

Isomers are the groups of compounds with the same exact masses and elemental compositions. In most cases, these compounds are similar in structure and polarity and also have similar cleavage pathways, which is difficult for analysts to deal with. Fortunately, the strategy that TOF-MS combined with IT-MS is a very powerful tool for the differentiation of isomers due to the accurate mass and multiple stages ability.

One example of our previous report [@bib12] showed that there are four compounds (a, b, c and d, see [Fig. 3](#f0015){ref-type="fig"}) identified from licorice with the same \[M−H\]^−^ ion at *m*/*z* 353. Firstly, by using HPLC-TOF-MS, four compounds could be assigned two group of isomers. Compound (a) and (b) \[group 1\] were assigned as licobenzofuran or licochalcone D with the accurate mass of \[M+H\]^+^ ions at *m*/*z* 355.1542, while compound (c) and (d) \[group 2\] as licoisoflavone or gancaonin L with the accurate mass of \[M+H\]^+^ ions at *m*/*z* 355.1179 by database-matching. Then we applied HPLC-QIT-MS^*n*^ to differentiate the compounds from each group. The QIT-MS spectra of group 1 showed that the product ion \[M−56−28−H\]^−^ at *m*/*z* 269 of compound (a) was triggered by initial loss of --C~4~H~8~, followed by loss of CO, as proposed in [Fig. 3](#f0015){ref-type="fig"}(a); and the product ion \[M−30−56−H\]^−^ at *m*/*z* 267 of compound (b) was produced by initial lose of --CH~2~O, followed by the elimination of --C~4~H~8~, as depicted in [Fig. 3](#f0015){ref-type="fig"}(b). Thus, the compounds (a) and (b) were tentatively characterized as licobenzofuran and licochalcone D, respectively. As to group 2, the product ion \[M−68−H\]^−^ at *m*/*z* 285 and \[M−56−H\]^−^ at *m*/*z* 297 were for both compounds triggered by initial loss of --C~3~O~2~ at *m*/*z* 68 and of --C~4~H~8~, respectively. When the product ion at *m*/*z* 285 was further selected for MS^3^ analysis, the two compounds displayed different MS^3^ spectra. Compound (c) exhibited the product ion \[M−68−56−H\]^−^ at *m*/*z* 229 by sequential loss of --C~4~H~8~, while compound (d) yielded the product ion \[M−68−68−H\]^−^ at *m*/*z* 217 by sequential loss of --C~5~H~8~. The product ion at *m*/*z* 217 of compound (c) fragmented into two ions at *m*/*z* 199 and 189 in the MS^4^ spectra corresponding to the losses of H~2~O and CO, respectively. On the basis of the above deduced fragmentation behaviors, compound (c) and (d) were tentatively identified as licoisoflavone and gancaonin L, respectively. The possible fragment pathways are proposed in [Figs. 3](#f0015){ref-type="fig"}(c) and (d). From the discussion above we can draw the conclusion that the combination of TOF-MS and IT-MS has the complementary advantages, which is very suitable for the differentiation of isomers in complex HM samples.Figure 3The proposed fragmentation pathways of licobenzofuran (a), licochalcone D (b), licoisoflavone (c) and gancaonin L (d).

3.2. Study of metabolites {#s0065}
-------------------------

The metabolites in HM-treated biological matrices are always non-target or unknown constituents of extremely low concentration, which require high sensitivity, selectivity and strong identification ability of the analyzers. As discussed above, the combination of TOF-MS and IT-MS or hybrid-IT-TOF/MS technique both have all these abilities and are really suitable for the study of metabolites from HMs or HM-treated biological matrices. [Table 2](#t0010){ref-type="table"} summarizes the recent applications of this strategy on the study of metabolites. From the summarized data we can conclude that the applications are still limited possibly due to lacking of the global strategy for the analysis of complicated metabolites. However, with the development of mass spectrometer technique and data acquiring and processing strategy, the advantages of this integrated strategy for analysis of metabolites will be revealed, and the rapid, accurate analysis of the subtle metabolites in HMs and HM-treated biological samples will be achieved.Table 2Combination of TOF-MS and IT-MS for analysis of metabolites in HMs and HM-treated biological samples.AnalytesMetaboliteMatrixLC/stationary phaseAnalyzersYearRef.(+)-Praeruptorin B (dPB) and (+)-praeruptorin E (dPE) from *Peucedani* RadixHuman: dPB:B1--B9; dPE:E1--E13 rat: dPB:B1--B8; dPE:E1--E13Human and rat liver microsomesHPLC/C~18~IT-MS^*n*^; TOF-MS2011[@bib13]Traditional Chinese medicine tongxinluo1-Methyladenosine, indoxyl sulfate, hippuric acid, riboflavin, coproporphyrin, and p-cresol glucuronideEndothelial dysfunction rats urinaryUFLC/C~18~IT-TOF/MS^*n*^2011[@bib59]5 Schisandra lignans from *Schisandra* lignans extract44 metabolitesRat urineHPLC/C~18~IT-TOF/MS^*n*^2010[@bib60]Salvianolic acid A from *Salvia miltiorrhiza*5 metabolites including SalA-monoglucuronide, monomethyl-SalA-monoglucuronide, mono-methyl-SalA, dimethyl-SalA and dimethyl-SalA-monoglucuronide,Rat plasmaHPLC/C~18~IT-MS^*n*^; TOF-MS2009[@bib61]Tectorigenin7 phase II metabolitiesRat bileHPLC/C~18~IT-MS^*n*^; TOF-MS2008[@bib62]Ginkgolide B3 metabolites in urine;1 hydroxyl metabolite in liverRat urine and liverHPLC/C~18~IT-MS^*n*^; TOF-MS2008[@bib63]Interaction between tanshinone IIA and warfarinWarfarin metaboliteRat blood and urine, human serum albuminHPLC/C~18~IT-MS^*n*^; TOF-MS2008[@bib64]

4. Conclusion {#s0070}
=============

The manuscript reviews the general features and the recent applications of LC coupled with IT and TOF-MS for qualitative analysis of HMs. Based on the currently available literatures, the advantages of this approach were described and discussed. It gives complementary advantages and becomes one of the most important methods in the field of qualitative research of HMs or HM-treated biological samples.

The inherent characteristics of TOF-MS in accurate mass measurements and high resolution make this analyzer attractive in the qualitative analysis of chemical constituents in herbal samples. While the parent ion of the fragment ions acquired by TOF-MS may not be easier to confirm, the IT-MS should be a good solution due to its abilities of ion isolation and accumulation, as well as multiple stages analysis. The integration of TOF and IT-MS could facilitate the identification and structure elucidation of target and non-target compounds in complex HM matrices. Furthermore, multiple scans of natural products in MS^*n*^ modes and accurate mass measurements can be performed simultaneously using hybrid-IT-TOF/MS, which will achieve an unequivocal confirmation of the target analytes by increasing confidence about the origin of the fragment ions. The analysis procedures will also be simplified and the analysis time will be greatly reduced. In a word, all these features indicate that the strategy of LC coupled with TOF-MS and IT-MS is a powerful tool for the qualitative analysis of HMs and the application of LC-hybrid-IT-TOF/MS in HM analysis can be expected.
